ARCHIVES

Phase III Data of Antibody-Drug Conjugate Shows PFS Increase in HER2+ Disease

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

In Brief: Two New Section Chiefs Named In NCI Research Contracts Branch; S. 988 Markup Set For April 25

April 18, 1980

McCormick President-Elect of AACR; Garber To Start Term As President

March 25, 2011

Drug Combination Tested For B.C. Brain Metastases

January 25, 2008

NCI Advisory Group, Other Cancer Meetings

August 26, 1977

NCI Moves Ahead To Find “Less-Hazardous” Cigarette

April 19, 1974

Tamoxifen Trial Enrolls 19% Of Women Needed, Fisher Reports To NCAB

October 16, 1992